4176.0 Other Drugs: Treatment Issues

Tuesday, November 6, 2007: 2:30 PM
Poster

Board 1
An evaluation of state priorities, guidelines and funding for infectious disease services in substance abuse treatment programs
Steven Kritz, MD, Lawrence S. Brown, MD, MPH, FASAM, R. Jeffrey Goldsmith, MD, Edmund J. Bini, MD, MPH, Jim Robinson, MEd, Don Alderson, MS and John Rotrosen, MD
Board 2
Changes in hepatitis C virus (HCV) education and counseling delivery practices among drug treatment program staff participating in a targeted training
Corrine E. Munoz-Plaza, MPH, Shiela M. Strauss, PhD, Janetta Astone-Twerell, PhD, Don Des Jarlais, PhD, Marya Gwadz, PhD, Holly Hagan, PhD, Andrew Osborne, MS and Andrew Rosenblum, PhD
Board 3
Evidence on multiple treatment services and reassessment of treatment plans
Frank S. Pearson, PhD, Michael L. Prendergast, PhD, Deborah Podus, PhD, Peter Vazan, PhD, Zachary Hamilton, MA and Lisa Greenwell, PhD
Board 7
Staffing Patterns in Methadone Treatment: An Examination of Differences Across Treatment Programs
Laura J. Dunlap, PhD, Gary A. Zarkin, PhD and Brendan Wedehase, BA
Board 8
Substance Abuse Treatment Access: Relationship with Integration of EAP and Specialty Behavioral Health Benefits
Elizabeth L. Merrick, PhD, Constance M. Horgan, ScD, Dominic Hodgkin, PhD, Vanessa Azzone, PhD, Frank Holt, RN, BSN, Bernie McCann, MS, CEAP and Sharon Reif, PhD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs